Neurogene Inc. (NGNE)
NASDAQ·Healthcare·Biotechnology
$27.47
+1.55%
Mkt Cap $420.97M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (12 analysts)
$45.00
Range $45.00 – $45.00
Implied Upside
+63.8%
Consensus $45.00 vs current $27.47
NASDAQ·Healthcare·Biotechnology
$27.47
+1.55%
Mkt Cap $420.97M
Buy
4
Hold
0
Sell
0
Price Target (12 analysts)
$45.00
Range $45.00 – $45.00
+63.8%
Consensus $45.00 vs current $27.47